Mediastinal Germ Cell Tumors: Updates in Diagnosis and Management
| dc.contributor.author | Stram, Amanda R. | |
| dc.contributor.author | Kesler, Kenneth A. | |
| dc.contributor.department | Surgery, School of Medicine | en_US |
| dc.date.accessioned | 2022-04-08T16:03:43Z | |
| dc.date.available | 2022-04-08T16:03:43Z | |
| dc.date.issued | 2020-10 | |
| dc.description.abstract | Primary mediastinal nonseminomatous germ cell tumors represent a rare but important malignancy that occurs in otherwise young and healthy patients. Treatment is challenging and involves cisplatin-based chemotherapy followed by surgery to remove residual disease. Avoiding bleomycin-containing chemotherapy in the treatment of primary mediastinal nonseminomatous germ cell tumors is important. Prechemotherapy and postchemotherapy pathology as well as postoperative serum tumor markers are independent predictors of long-term survival. | en_US |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Stram, A. R., & Kesler, K. A. (2020). Mediastinal Germ Cell Tumors: Updates in Diagnosis and Management. Surgical Oncology Clinics of North America, 29(4), 571–579. https://doi.org/10.1016/j.soc.2020.06.005 | en_US |
| dc.identifier.issn | 1558-5042 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/28453 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.soc.2020.06.005 | en_US |
| dc.relation.journal | Surgical Oncology Clinics of North America | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | Author | en_US |
| dc.subject | Chemotherapy | en_US |
| dc.subject | Combined Modality Therapy | en_US |
| dc.subject | Mediastinal Neoplasms | en_US |
| dc.subject | Mediastinal tumors | en_US |
| dc.subject | Thoracic surgery | en_US |
| dc.title | Mediastinal Germ Cell Tumors: Updates in Diagnosis and Management | en_US |
| dc.type | Article | en_US |